Despite the complex and sometimes formidable regulation and controls, the Chinese pharmaceutical market remains dynamic and potentially lucrative. Especially now, after China's entry into the WTO and through the introduction of internationally accepted trading and regulation standards., the industry will further open and develop. Therefore, the key to a foreign company's success is having a sound strategy to guide it through the regulatory maze. This includes a firm grasp on regulations and how to work with regulators, distributors and local partners. Knowledge of real-market practices and competitors is also needed. While it does not in any way promise to be a smooth and easy ride, China does promise opportunities for foreign companies with enough staying power.
